According to statistics, China has become the largest country in cosmetics consumption. The pursuit of beauty is not only about appearance, but also a way to show personal character and value. People with different personalities have different needs for beauty. What's more, people's needs for beauty will be different at every age and every important occasion. China is a dynamic, consuming and inclusive market. The core of different cosmetic brands is the difference in the use of New Cosmetic Ingredients. The use of new cosmetic ingredients will bring new feelings and convey new brand concepts to consumers.
You may ask, how to apply for and make new cosmetic ingredient listed in China?
We can help you.
We can provide one-stop registration and services for new cosmetic ingredients.
Some answers and situations you might want to know.
CONTACT US
TEL:0086-0755-86591493
Related Services:
· Application for new cosmetic ingredients in China
· In vitro efficacy evaluation
· Safety evaluation
· Clinical efficacy evaluation
Q1.How to understand and define New Cosmetic Ingredient in China? The regulations in China?
In China, a new cosmetic ingredient is a natural or artificial ingredient that is applied in cosmetic products for the first time in China.
The Inventory of Existing Cosmetic Ingredients in China (IECIC 2021) issued by the National Medical Products Administration on April 27, 2021, replaced by the previous version (IECIC 2015) as the standard for judging cosmetic ingredients in China. Ingredients not listed on IECIC 2021 have to be registered or notified before their use in cosmetics.
Existing or listed cosmetic ingredients that are modified for purpose of use or used safely should also be registered with NCI.
Q2.What need to be prepared if appling for a new cosmetic ingredient in China?
In the submission,the source and research situation of new raw materials, manufacturing process and its quality control situation and safety assessment situation should be clearlystated.Under limited conditions of use, the safety and risk controllability of using NCI should be fully demonstrated.When citing scientific literature or regulatory data, it should be relevant to the new ingredient for registration or filing.
The source of NCI, purpose of use,specification of use, scope of application and other restrictive conditions stated therein shall apply to the NCI registered or filed.
Information List
No. | File Name | Key Information |
1 | Overview of the Safety Risk Monitoring and Evaluation System for NCI Registrants/Filers | The registrant/filer of overseas NCIs should also briefly describe the mechanisms and measures for information exchange, data sharing, and risk linkage with domestic responsible persons in terms of safety risk monitoring and evaluation. The domestic responsible person should briefly describe the specific measures for cooperating with the registrant/filer of NCIs in safety risk monitoring and evaluation, including the setting of job responsibilities, and relevant systems for safety risk monitoring and evaluation. |
2 | Information Application Form For NCI Registrant/filer | NCI name / usage information/registrant/filer/domestic responsible person information |
3 | Development Report | Basic information: NCI name, source, composition, relative molecular mass, molecular formula, chemical structure, physical and chemical properties, etc. |
4 | Usage information: usage specifications, purpose of use, application or scope of use, safe use amount, duration of use, precautions, warnings, etc. The status and approval status of NCI used in cosmetics overseas. | |
5 | Functional basis: Judging from scientific literature, regulatory data, laboratory research data or human efficacy evaluation test data, it can be proved that NCI has the same purpose of use. | |
6 | Brief Description of Preparation Process | Whether the safety risk substances and their control measures are likely to be introduced in the main process steps, process parameters, and production processes. |
7 | Stability Test Data | Stability test data: destructive test, accelerated test, long-term storage test |
8 | Quality Control Standards | Quality specifications and inspection methods, possible safety risk substances and their control standards, etc. |
9 | Security Assessment Report | Toxicological safety evaluation data, safety risk evaluation data |
10 | Skills Requirement | Prepared in combination with relevant technical information of NCI for registration/filing information disclosure |
11 | Other information useful for filing | Other relevant information that is helpful for registration/filing. |